| 臺大學術典藏 |
2020-05-04T08:09:16Z |
Convergence of the Exponentiated Gradient Method with Armijo Line Search
|
Li, Y.-H.;Cevher, V.; Li, Y.-H.; Cevher, V.; YEN-HUAN LI |
| 臺大學術典藏 |
2020-05-04T08:09:16Z |
MIMO-OFDM PHY Integrated (MOPI) scheme for confidential wireless transmission
|
Cheng, J.-P.;Li, Y.-H.;Yeh, P.-C.;Cheng, C.-M.; Cheng, J.-P.; Li, Y.-H.; Yeh, P.-C.; Cheng, C.-M.; YEN-HUAN LI |
| 臺大學術典藏 |
2020-03-31T08:25:19Z |
Induced voltage measurements on a YBa 2Cu 3O 7-δ superconducting thin film due to a pair of rotating magnets
|
Lin, J. G.; Wang, L. M.; Chan, W. C.; Chiang, C. H.; Li, Y. H. |
| 臺大學術典藏 |
2020-03-24T03:47:55Z |
The Asia-Pacific Society of Cardiology (APSC) expert committee consensus recommendations for assessment of suspected acute coronary syndrome using high-sensitivity cardiac troponin T in the emergency department
|
Chew D.P.;Youn J.-C.;Phrommintikul A.;CHIEN-CHANG LEE;Devasia T.;Chu F.-Y.;Than M.;Lukito A.A.;Lim S.H.;Li Y.-H.;Dung H.T.;Cheng F.;Aw T.C.;Shiozaki M.;Kasim S.;Giannitsis E.;AbdelWareth L.;Inoue K.;Jack Tan W.C.; Jack Tan W.C.; Inoue K.; AbdelWareth L.; Giannitsis E.; Kasim S.; Shiozaki M.; Aw T.C.; Cheng F.; Dung H.T.; Li Y.-H.; Lim S.H.; Lukito A.A.; Than M.; Chu F.-Y.; Devasia T.; CHIEN-CHANG LEE; Phrommintikul A.; Youn J.-C.; Chew D.P. |
| 臺大學術典藏 |
2020-03-23T07:19:32Z |
Development and characterization of a specific anti-caveolin-1 antibody for Caveolin-1 functional study in human, goat and mouse
|
Ke M.-W.; Jiang Y.-N.; Li Y.-H.; Tseng T.-Y.; Kung M.-S.; CHIUN-SHENG HUANG; Cheng W.T.-K.; Hsu J.-T.; Ju Y.-T. |
| 臺大學術典藏 |
2020-03-05T06:05:32Z |
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
|
LI-KAI TSAI; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H. |
| 臺大學術典藏 |
2020-03-05T06:05:29Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; LI-KAI TSAI; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Chau-Chung Wu;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L.; Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; CHAU-CHUNG WU; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T05:42:45Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:38Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T05:42:36Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L.; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:32Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-04T05:35:03Z |
Theory of mind in patients with temporal lobe epilepsy
|
Li Y.-H.; MING-JANG CHIU; Yeh Z.-T.; Liou H.-H.; Cheng T.-W.; Hua M.-S. |
| 臺大學術典藏 |
2020-03-02T12:10:57Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:46Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:43Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
SUNG-CHUN TANG;Lin J.-L.;Hwang J.-J;Wu Y.-W;Yang Y.-C;Chan H.-L;Tsai L.-K;Fu W.-R;Chao A.-C;Lee M.-Y;Wang C.-Y;Huang W.-C;Chang W.-T;Chen Z.-C;Huang C.-W;Chen P.-W;Wu C.-K;Chang K.-C;Huang C.-C;Yeh H.-I;Wu C.-C;Wang Y.-C;Lin T.-H;Chen J.-W;Li Y.-H; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I; Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L. |
| 臺大學術典藏 |
2020-03-02T12:10:30Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
SUNG-CHUN TANG;Yeh H.-I.;Li Y.-H;Huang Y.-H;Chen P.-S;Chien S.-C; Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-02T07:40:40Z |
A method to prepare magnetic nanosilicate platelets for effective removal of microcystis aeruginosa and microcystin-LR
|
Chang, S.-C.; Lu, B.-L.; Lin, J.-J.; Li, Y.-H.; Lee, M.-R.; JIANG-JEN LIN |
